NCT04489264View on ClinicalTrials.gov

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2025

Conditions
Peripheral T Cell Lymphoma
Interventions
DRUG

Transplant, Autologous

high dose chemotherapy followed by autologous stem cell transplantation

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University

OTHER